Prevention and treatment of retinal ischemia and edema
Patent 6524581 Issued on February 25, 2003. Estimated Expiration Date: December 29, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/130.1, IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL530/387.1Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed
The present invention relates to methods of treating retinopathy, retinal ischemia and/or retinal edema comprising administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist.
Other References
Branch, A.D. TIBS, vol. 23, Feb. 1998, pp. 45-50.
Jen et al., Stem Cells 2000; 18:307-319.
Green et al., J. A. Coll. Surg., (Jul. 2000).
Kleinberg et al., Am. J. Health-Syst. Pharm., vol. 52, pp. 1323-1336 (Jun., 1995).
Yagi et al., Diabetes, vol. 44, No. 7, pp. 744-752 (Jul. 1995).
Rao et al., Alterations in Stimulus-Induced Integrin Expression in Peripheral Blood Neutrophils of Patients With Diabetic Retinopathy, The American Journal of the Medical Sciences, Mar. 1997, vol. 313, No. 3, pp. 131-137.
Hamada K, et al., "Involvement of Mac-1-mediated Adherence and Sphingosine 1-phosphate in Survival of Phorbol Eser-treated U937 Cells," Biochemical and Biophysical Research Communications, 244(3): 745-750 (1998)
Kelly, T.A., et al., "Cutting Edge: a Small Molecule Antagonist of Lfa-1-mediated Cell Adhesion," J. Immunology, 163(10): 5173-5177 (1999)
Shannon, J.P., et al., "Novel cyclic peptide inhibits intercellular adhesion molecule-1-mediated cell aggregation," Journal of Peptide Research, 58(2): 140-150 (2001)
Zhu, G.D., et al., "Selective Inhibition of Icam-1 and E-selectin Expression in Human Endothelial Cells. 2. Aryl Modifications of 4-(Aryloxy) Thieno[2,3-c]pyridines with Fine-tuning at C-2 Carbamides," Journal of Medicinal Chemistry, 44(21): 3469-3487 (2001)
Cohen Tervaert, J.W., et al., "Novel Therapies for Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis," Current Opinion in Nephrology and Hypertension, 10(2): 211-217 (2001)
Dragun, D. and Haller, H., "Diapedesis of Leukocytes: Antisense Oligonucleotides for Rescue," Experimental Nephrology, 7(2): 185-192 (1999)
Tsuji, T. et al., "Integrin B2 (Cd18)-mediated Cell Proliferation of HEL Cells of a Hematopoietic-supportive Bone Marrow Stromal Cell Line, Hes 5 Cells," Blood, 91(4) 1263-1271 (1998)
Nathan,D.M., "The Pathophysiology of Diabetic Complications: How Much Does the Glucose Hypothesis Explain?," Annual Intern Medicine, 123(1Pt 2): 86-89 (1996)
Porta, M., "Diabetic Retinopathy and Metabolic Control," European Journal of Ophthalmology, 3(4): 207-215 (1993)
Lightman, S., "Does Aldose Reductase Have a Role in the Development of the Ocular Complications of Diabetes?," Eye, 7(Pt 2): 238-241 (1993)
Frank, R.N., "On the Pathogenesis of Diabetic Retinopathy. A 1990 Update," Ophthalmology, 98(5): 586-593 (1991)
Wiedemann, P., "What Is Th Etiology of Diabetic Retinopathy?," Ophthalmologe, 90(5): 426-433 (1993)
Kessler, L, et al., "Von Willebrand Factor in Diabetic Angiopathy," Diabetes Metabolism , 24(4): 327-336 (1998)
Ways, D.K., and Sheetz, M.J., "The Role of Protein Kinase C in the Development of the Complications of Diabetes," Vitamin Hormone, 60: 149-193 (2000)
Antonetti, D.A., et al., "Molecular Mechanisms of Vascular Permeability in Diabetic Retinopathy," Seminar of Ophthalmology, 14(4): 240-248 (1999)
Ambati, J., et al., "Transscleral Delivery of Bioactive Protein to the Choroid and Retina," Investigative Ophthalmology & Visual Science, 41(5): 1186-1191 (2000)
Henry, S.P., et al., "Antiviral Activity and Ocular Kinetics of Antisense Oligonucleotides Designed to Inhibit Cmv Replication," Investigative Ophthalmology & Visual Science, 42(11): 2646-2651 (2000)
Olson, J. A. et al., "Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration," Diabetolgia, 40(10):1166-71 (Oct. 1997)
Uchio E. et al., "Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1, " Investigative Ophthalmology and Visual Science, 35(5):2626-31 (Apr. 1994)
Henley W. L. et al., "Leukocyte migration inhibition in chronic ophthalmic disorders. 5. Diabetic retinopathy and the effect of photocoagulation," American Journal of Ophthalmology, 76(2):279-83 (Aug. 1973)
Barouch F. C. et al., "Integrin-mediated neutropil adhesion and retinal leukostasis in diabetes," Investigative Ophthalmology and Visual Science, 41(5):1153-8 (Apr. 2000)
Ambati, J., et al., IOVS, 41(5):1186-1191 (2000)
Lawrence M. B. et al., "Leukocytes Roll on a Selectin at Physiologic Flow Rates: Distinction from and Prerequisite for Adhesion Through Integrins," Cell, vol. 65:859-873 (1991)
Arnold, T. et al., "Increased PMN Adherence on Endothelial Cells After Hypoxia: Involvement of PAF, CD18/CD11b, and ICAM-1," American Physiological Society C1102-C1110 (1993)
Springer, T. A., "Traffic Signals for Lymphocyte Recirculation and Leukocyte Emigration: The Multistep Paradigm," Cell, vol. 76:301-314 (1994)
Schmid-Schonbein, G.W., "Granulocyte Activation and Capillary Obstruction," Liepshc DW (ed): Blood Flow in Large Arteries: Applications to Atherogenesis and Clinical Medicine. Monogr Atheroscler, Basel, Karger, vol. 15:150-159 (1990)
Panes, J. et al., "Diabetes Exacerbates Inflammatory Responses to Ischemia-Reperfusion," Circulation, vol. 93:161-167(1996)
Lu, M. et al., "VEGF Increases Retinal Vascular ICAM-1 Expression and Neutrophil Adhesion to Endothelial Cells," IOVS, vol. 39(4) (1998) (Abstract)
Limb, G. A. et al., "Evidence of Chronic Inflammation in Retina Excised After Relaxing Retinotomy for Anterior Proliferative Vitreoretinopathy," Graefe's Arch Clin. Exp. Ophthalmol, vol. 234:213-220 (1996)
Douglas, J. T. et al., "Vascular and Platelet Adhesion Molecules: E-Selectin, ICAM-1, VCAM-1, GMP-140 and Platelet Derived Growth Factor in Diabetes," (Abstract), Fibrinolysis, 8 (Suppl. 1): 132 (1994)
Lisby, S. et al., "Intercellular Adhesion Molecule-I (ICAM-I) Expression Correlated to Inflammation," British Journal of Dermatology, vol. 120:479-484 (1989)
Ashton, N. "Pathogenesis of Diabetic Retinopathy," edited by H.L. Little, et al., New York, Thieme Stratton (1983) Diabetic Retinopathy 85-106
Chakrabarti, D. et al., "IFN- Induces Autoimmune T Cells Through the Induction of Intracellular Adehesion Molecule-1 and B7.2," J. of Immunol. vol. 157:522-528 (1996)
Lampeter, E. R. et al., "Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM," Diabetes vol. 41:1668-1671 (1992)
Heidenkummer, H. et al., "Intercellular Adhesion Molecule-1 (ICAM-1) and Leukocyte Function-Associated Antigen-1 (LFA-1) Expression in Human Epiretinal Membranes," Graefe's Arch. Clin. Exp. Ophthalmol. vol. 230:483-487 (1992)
Albertini, J. P. et al., "Are Soluble Adhesion Glycoproteins a Marker for Coronary Lesions in the Diabetic Patient?," (Abstract No. 1561) Abstracts of the 16th International Diabetes Federal Congress, Diabetologia, vol. 40, Suppl. 1, (Jun., 1997)
Schmid-SchonBein, G.W., "The Damaging Potential of Leukocyte Activation in the Microcirculation," Angiology--The Journal of Vascular Diseases 45-56 (1993)
Roep, B. O. et al., "Soluble Forms of Intercellular Adhesion Molecule-1 in Insulin-Dependent Diabetes Mellitus," The Lancet, vol. 343:1590-1593 (1994)
Kohner, E.M. et al., Diabetic Retinopathy 25:1985-1102 (1975)
Schroder, S. et al., "Activated Monocytes and Granulocytes, Capillary Nonperfusion, and Neovascularization in Diabetic Retinopathy," American Journal of Pathology, vol. 139(1):81-100 (1991)
McLeod, S. D. et al., "Enhanced Expression of Intracellular Adhesion Molecule-1 and P-Selectin in the Diabetic Human Retina and Choroid," American Journal of Pathology, vol. 147(3):642-653 (1995)
Larson, R. S. et al., "Structure and Function of Leukocyte Integrins," Immunological Reviews, vol. 114:181-217 (1990)
De Mesmaeker, A. et al., "Antisense Oligonucleotides," Acc. Chem. Res., vol. 28:366-374 (1995)
Setlow, J. K., Genetic Engineering, 20:143-151 (1988)
Robinson, G.S. et al., "Oligodeoxynucleotides Inhibit Retinal Neovascularization in a Murine Model of Proliferative Retinopathy," Proc. Natl. Acad. Sci. vol. 93:4851-4856 (1996)
Miyamoto, K. et al., "In Vivo Demonstration of Increased Leukocyte Entrapment in Retinal Microcirculation of Diabetic Rats," Invest. Ophthalmol. Vis. Sci. 39(11):2190-2194 (1998)
Miyamoto K. et al., "In Vivo Quantification of Leukocyte Behavior in the Retina During Endotoxin-Induced Uveitis," Invest. Ophthalmol. Vis. Sci. 37(13):2708-2715 (1996)
Nishiwaki H. et al., "Visualization and Quantitative Analysis of Leukocyte Dynamics in retinal Microcirculation of Rates," Invest. Ophthalmol. Vis. Sci. 37(7):1341-1347 (1996)
Tilton, R.G. et al., "Prevention of Diabetic Vascular Dysfunction by Guanidines Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation," Diabetes 42(2):221-232 (1993)
Tilton, R.G. et al., "Vascular Dysfunction Induced by Elevated Glucose Levels in Rats is Mediated by Vascular Endothelial Growth Factor," J. Clin. Invest. 99(9):2192-2202 (1997)
Hynes, R.O., "Integrins: Versatility, Modulation, and Signaling in Cell Adhesion," Cell, 69:11-25 (Apr. 3, 1992)
Faveeuw, C., et al., "Expression of Homing and Adhesion Molecules in Infiltrated Islets of Langerhans and Salivary Glands of Nonobese Diabetic Mice," Journal of Immunology, 152:5969-5978(1994)
Hunger, R.E., et al., "Inhibition of Submandibular and Lacrimal Gland Infiltration in Nonobese Diabetic Mice by Transgenic Expression of Soluble TNF-receptopr p55," J. Clin. Invest., 98:954-961 (1996)
Prieto, J., et al., "Induction of Intercellular Adhesion Molecule-1 (CD54) on Isolated Mouse Pancreatic ଲ Cells by Inflammatory Cytokines," Clinical Immunology and Immunopathology, 65(3):247-253 (Dec., 1992)
Papaccio, G., et al., "Pancreatic duct inflammatory infiltration in the nonobese diabetic (NOD) mouse," J. Anat., 185:465-470 (1994)
Guha, M., et al., "Molecular and cellular alterations in monocyte/macrophages in response to hyperglycemia and inflammatory cytokines," Blood--Journal of the American Society of Hematology, 90(10): Abstract No. 2882 (Nov. 15, 1997)
Yoshioka, N., et al., "PS 49 Retinopathy--Experimental and Pathogenesis," Diabetologia--Journal of the European Association for the Study of Diabetes, 40(1): Abstract No. 1925 (Jun. 1997)
DeSouza, C.A., et al., "Elevated levels of Circulating Cell Adhesion Molecules in Uncomplicated Essential Hypertension," The FASEB Journal, 11(3):Abstract No. 2696 (Feb. 28, 1997)
Vejlsgaard, G.L., et al., "Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas," J. Am. Acad. Dermatol., 20:782-790 (1989)
Luscinskas, F.W., et al., "Integrins and dynamic regulators of vascular function", FASEB J., 8:929-938 (1994)
Rosales, C., et al., "Signal transduction by cell adhesion receptors in leukocytes", Leukocyte Biol, 57:189-198 (1995)
Braun, R.D., et al., "Decreased deformability of Polymorphonuclear leukocytes in diabetic cats", Microcirculation, 3:271-278 (1996)
Miyamoto, K., et al., "Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition", Proc Natl Acad Sci USA, 96(19):10836-10841 (1999)
Diamond, D.S., et al., "A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen", J Cell Biol, 120:545-556 (1993)
Davenpeck, K.L., et al., "Rat neutrophils express alpha4 and beta1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MadCAM-1)", Blood, 91:2341-2346 (1998)
Morohoshi, M., et al., "Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro", Diabetes, 45:954-959 (1996)
Kim, J.A., et al., "Evidence that glucose increases monocyte binding to human aortic endothelial cells", Diabetes, 43:1103-1107 (1994)
Manduteanu, I., et al., "High glucose induces enhanced moncyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD18", Endothelium, 6:315-324 (1999)
Springer, T.A., "Adhesion receptors of the immune system," Nature (London), 346:425-434 (1990)
Luscinskas, F.W., et al., "Cytokine-Activated Human Endothelial Monolayers Support Enhanced Neutrophil Transmigration via a Mechanism Involving Both Endothelial-Leukocyte Adhesion Molecule-1 and Intercellular Adhesion Molecule-1," J. Immunol., 146:1617-1625 (1991)
Del Maschio, A., et al., "Polymorphonuclear Leukocyte Adhesion Triggers the Disorgainzation of Endothelial Cell-to-Cell Adherens Junction," J. Cell Biol., 135:497-510 (1996)
Bolton, S.J., et al., "Loss of the Tight Junction Proteins Occludin and Zonula Occludens-1 from Cerebral Vascular Endothelium During Neutrophil-Induced Blood-Brain Barrier Breakdown In Vivo," Neuroscience, 86:1245-1257 (1998)
Kurose, I., et al., "Molecular Determinants of Reperfusion-Induced Leukocyte Adhesion and Vascular Protein Leakage," Circ. Res., 74:336-343 (1994)
Vinores, S.A., et al., "Rapid Communication," Am. J. Pathol., 134:231-235 (1989)
Yamana, Y., et al., "Reflow of obstructed capillaries in the maculae of humans with diabetic retinopathy, observed by fluorescein angiography," Br. J. Ophthalmol., 72:660-665 (1988)
Bandello, F., et al., "Spontaneous Regression of Neovascularization at the Disk and Elsewhere in Diabetic Retinopathy," Am. J. Ophthalmol., 122:494-501 (1996)
Takahaashi, K., et al., "Reperfusion of Occluded Capillary Beds in Diabetic Retinopathy," Am. J. Ophthalmol., 126:791-797 (1998)
Wierusz-Wysocka, B., et al., "Evidence of Polymorphonuclear Neutrophils (PMN) Activation in Patients with Insulin-Dependent Diabetes Mellitus," J. Leukocyte Biol., 42:519-523 (1987)
Lutty, G.A., et al., "Relationship of Polymorphonuclear Leukocytes to Capillary Dropout in the Human Diabetic Choroid," Am. J. Pathol., 151:707-714 (1997)
Tolentino, M.J., et al., "Intravitreal injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate", Ophthalmology, 103:1820-1828 (1996)
Okamoto, N., et al., "Transgenic mice with increased expression of vascular endothelial growth factor in the retina", Am. J. Pathol., 151:281-291 (1997)
Aiello, L.P., et al., "Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor", Daibetes, 46:1473-1480 (1997)
Adamis, A.P., et al., "Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy", Am. J. Ophthalmol., 118:445-450 (1994)
Aiello, L.P., et al., "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders", N Eng J Med, 331:1480-1487 (1994)
Malecaze, F., et al., "Detection of vascular endothelial growth factor messanger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy", Arch. Ophthalmol., 112:1476-1482 (1994)
Melder, R.J., et al., "During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium", Nature Med, 2:992-997 (1996)
Becker, M.D., et al., "In vivo significance of ICAM-1-dependent leukocyte adhesion in early corneal angiogenesis", Invest. Ophthalmol. Vis. Sci., 40:612-618 (1999)
Detmar, M., et al., "Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice", J Invest Dermatol, 111:1-6 (1998)
Yaccino, J.A., et al., "Physiological transport properties of cultured retinal microvascular endothelial cell monolayers", Curr Eye Res, 16:761-768 (1997)
Esser, S., et al., "Vascular endothelial growth factor induces endothelial fenestrations in vitro", J Cell Biol, 140:947-959 (1998)
Roberts, W.G., et al., "Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor", J Cell Sci, 108:2369-2379 (1995)
Roberts, W.G., et al., "Neovasculature induced by vascular endothelial growth factor is fenestrated", Cancer Res, 57:765-772 (1997)
Shen, H., et al., "Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes", Blood, 81:2767-2773 (1993
December 29, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
